As expected, those with baseline BMI ≥ 35.0 kg/m 2 demonstrated a greater reduction in BMI, although this did not reach statistical significance ( p = 0.06).
← all excerpts
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study.
1
0.0600
0.0600